Feature

Brexanolone is a synthetic form of allopregnanolone. It is an FDA-approved injectable medication specifically for the treatment of postpartum depression. Clinical studies have shown that after injection, it can take effect quickly within a few hours, and 75% of patients reported improvement in their symptoms.
Its main ingredient is Allopregnanolone, which is a pharmaceutical raw material used for postpartum depression.
Allopregnanolone is a hormone that helps relieve depression and anxiety by inhibiting neural activity.

Specification-COA

Function and Application

1. Antidepressant and antianxiety. From a pharmacological point of view, Allopregnanolone acts as a neurosteroid, a modulator of GABAA receptors, which can activate GABAA receptors inside and outside the synapse and produce antidepressant and antianxiety effects.
   It can relieve the symptoms of postpartum depression in a shorter period of time and has a fast onset of action.
2. Antiviral effect on influenza virus. Studies have found that allopregnanolone has biological activity that inhibits the replication of influenza A virus.
   It exerts antiviral effects by interfering with the transport of viral nucleoprotein (NP).
   In short, allopregnanolone, as a new type of influenza virus NP inhibitor, has potential development and application value.